Cargando…

Immune profiling reveals prognostic genes in high-grade serous ovarian cancer

High-grade serous ovarian cancer (HGSOC) is a heterogeneous disease with diverse clinical outcomes, highlighting a need for prognostic biomarker identification. Here, we combined tumor microenvironment (TME) scores with HGSOC characteristics to identify immune-related prognostic genes through analys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yong, Xia, Lingfang, Zhao, Ping, Deng, Yu, Guo, Qinhao, Zhu, Jun, Chen, Xiaojun, Ju, Xingzhu, Wu, Xiaohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343445/ https://www.ncbi.nlm.nih.gov/pubmed/32544083 http://dx.doi.org/10.18632/aging.103199

Ejemplares similares

Identification of Chemoresistance-Associated Key Genes and Pathways in High-Grade Serous Ovarian Cancer by Bioinformatics Analyses
por: Wu, Yong, et al.
Publicado: (2020)

The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer
por: Feng, Zheng, et al.
Publicado: (2018)

Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer
por: Feng, Zheng, et al.
Publicado: (2016)

Hormone receptor expression profiles differ between primary and recurrent high-grade serous ovarian cancers
por: Feng, Zheng, et al.
Publicado: (2017)

A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression
por: Feng, Zheng, et al.
Publicado: (2016)

Expression of hypothalamic-pituitary-gonadal axis-related hormone receptors in low-grade serous ovarian cancer (LGSC)
por: Feng, Zheng, et al.
Publicado: (2017)

Validation of the prognostic value of various lymph node staging systems for cervical squamous cell carcinoma following radical surgery: a single-center analysis of 3,732 patients
por: Guo, Qinhao, et al.
Publicado: (2020)

Homologous recombination repair gene mutations show no survival benefits in Chinese high-grade serous ovarian cancer patients
por: Feng, Zheng, et al.
Publicado: (2021)

HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway
por: Wu, Yong, et al.
Publicado: (2021)

Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer
por: Yong, Wu, et al.
Publicado: (2018)

Comparison of different lymph node staging systems in patients with node-positive cervical squamous cell carcinoma following radical surgery
por: Guo, Qinhao, et al.
Publicado: (2020)

Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
por: Feng, Zheng, et al.
Publicado: (2023)

Effect of the Number of Removed Lymph Nodes on Survival in Patients with FIGO Stage IB-IIA Cervical Squamous Cell Carcinoma following Open Radical Hysterectomy with Pelvic Lymphadenectomy: A Retrospective Cohort Study
por: Guo, Qinhao, et al.
Publicado: (2021)

Extraperitoneal laparoscopy for para-aortic lymphadenectomy in endometrial carcinoma staging: an approach with higher efficiency
por: Zhang, Wei, et al.
Publicado: (2021)

Single‐cell transcriptomes reveal heterogeneity of high‐grade serous ovarian carcinoma
por: Hao, Qian, et al.
Publicado: (2021)

Overexpression of NPTX2 Promotes Malignant Phenotype of Epithelial Ovarian Carcinoma via IL6-JAK2/STAT3 Signaling Pathway Under Hypoxia
por: Han, Xiaotian, et al.
Publicado: (2021)

Long non‐coding RNA SNHG6 promotes cell proliferation and migration through sponging miR‐4465 in ovarian clear cell carcinoma
por: Wu, Yong, et al.
Publicado: (2019)

A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study
por: Feng, Zheng, et al.
Publicado: (2018)

The RNA-Binding Protein CELF2 Inhibits Ovarian Cancer Progression by Stabilizing FAM198B
por: Guo, Qinhao, et al.
Publicado: (2020)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

Identification of Potential Prognostic Competing Triplets in High-Grade Serous Ovarian Cancer
por: Zhao, Jian, et al.
Publicado: (2021)

Extracellular microRNA profiling for prognostic prediction in patients with high‐grade serous ovarian carcinoma
por: Yoshida, Kosuke, et al.
Publicado: (2021)

Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
por: Zhang, Lu, et al.
Publicado: (2021)

Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer
por: Xie, Hongyu, et al.
Publicado: (2017)

Prognostic gene expression signature for high-grade serous ovarian cancer
por: Millstein, J., et al.
Publicado: (2020)

SPOP promotes cervical cancer progression by inducing the movement of PD-1 away from PD-L1 in spatial localization
por: Wu, Jiangchun, et al.
Publicado: (2022)

Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence
por: Wu, Jiangchun, et al.
Publicado: (2023)

DNA methylation-based profiling reveals distinct clusters with survival heterogeneity in high-grade serous ovarian cancer
por: Wang, Jieyu, et al.
Publicado: (2021)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

The Role of the Extracellular Matrix and Tumor-Infiltrating Immune Cells in the Prognostication of High-Grade Serous Ovarian Cancer
por: Belotti, Yuri, et al.
Publicado: (2022)

T-Cell Receptor Repertoire Characteristics Associated with Prognostic Significance in High-Grade Serous Ovarian Carcinoma
por: Kim, Ju-Won, et al.
Publicado: (2023)

Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients
por: Feng, Zheng, et al.
Publicado: (2016)

Prognostic significance of intra-tumoral budding in high-grade serous ovarian carcinomas
por: Hachisuga, Toru, et al.
Publicado: (2022)

Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
por: Zhou, Huimei, et al.
Publicado: (2020)

Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging
por: Kulbe, Hagen, et al.
Publicado: (2020)

An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
por: Shi, Fengjuan, et al.
Publicado: (2021)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas
por: Hiramatsu, Kosuke, et al.
Publicado: (2016)

Molecular classification and immunologic characteristics of immunoreactive high‐grade serous ovarian cancer
por: Liu, Zheran, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3uguscoo5ulun2r6cuv395u9cb